29 results on '"Stanzione M"'
Search Results
2. Tuning of polyurethane foam mechanical and thermal properties using ball-milled cellulose
3. Characterization of sustainable polyhydroxyls, produced from bio-based feedstock, and polyurethane and copolymer urethane-amide foams
4. Synthesis and characterization of sustainable polyurethane foams based on polyhydroxyls with different terminal groups
5. Peculiarities of vanillin release from amino-functionalized mesoporous silica embedded into biodegradable composites
6. DAA-based regimens in HBsAg/anti-HCV positive patients: The need to control HBV replication to avoid HBV reactivation
7. An elevated degree of genetic variability characterizes Hepatitis Delta Antigen (HDAg) and correlates with high levels of serum HDV-RNA: Implication for disease progression and design of new pharmacological targets
8. DAA-based regimens in HBsAg/anti-HCV positive patients: the need to control HBV replication to avoid HBV reactivation
9. Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA
10. HBV-HDV co-infection constrains HBV genetic evolution in HBsAg
11. The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B
12. THE TM6SF2 E167K VARIANT IS AN INDEPENDENT PREDICTOR OF SEVERE LIVER STEATOSIS IN CHRONIC HEPATITIS C
13. P660 THE EFFECT OH HEPATITIS B VIRUS INFECTION ON STEATOSIS IN HEPATITIS C VIRUS COINFECTED PATIENTS: THE BOSTIC STUDY
14. P731 CANNABINOID RECEPTOR 2-63 QQ VARIANT IS ASSOCIATED WITH PERSISTENTLY NORMAL AMINOTRANSFERASE SERUM LEVELS IN CHRONIC HEPATITIS C
15. Cannabinoid receptor 2-63 Qq variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C
16. 446 ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT
17. T-10 Acute exacerbation of chronic hepatitis C: clinical presentation, outcome and response to anti-HCV treatment
18. F-18 Etiological and clinical characteristics of patients with liver cirrhosis at the onset of first hepatic decompensation: final results of a prospective multicentre AISF collaborative study (EPASCO)
19. T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection
20. 154 LOW RATE OF ONE-YEAR MORTALITY IN PATIENTS WITH STAGE 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (A.I.S.F.)-EPASCO PROSPECTIVE MULTICENTRE STUDY
21. RETROSPECTIVE, OBSERVATIONAL, MULTICENTRE STUDY ON THE ITALIAN POPULATION AFFECTED BY CHRONIC HEPATITIS C WHO FAILED TO CLEAR HCV-RNA AFTER THE COMBINATION THERAPY (PEG-IFN AND RIBAVIRIN): NADIR STUDY
22. 820 HCV GENOTYPE 4 IN SUBJECTS UNDERGOING ANTIVIRAL TREATMENT IN ITALY
23. [639] ANTIVIRAL TREATMENT IN CHRONIC HBV/HCV COINFECTION: VIROLOGICAL CHANGES IN THREE COMPARTMENTS (PLASMA, PBMC AND LIVER TISSUE) AND CLINICAL OUTCOME
24. Early discontinuation of ribavirin in HCV genotype 2 and 3 patients undergoing short-treatment duration with Peg-interferon alfa 2a and ribavirin
25. P.324 Pegylated interferon alpha-2b monotherapy and in combination with ribavirin in chronic hepatitis delta
26. 478 Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study
27. Peculiarities of vanillin release from amino-functionalized mesoporous silica embedded into biodegradable composites
28. CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection
29. DAA-based regimens in HBsAg/anti-HCV positive patients: The need to control HBV replication to avoid HBV reactivation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.